ACTU Competitors & Alternatives
Compare Actuate Therapeutics, Inc. Common stock with similar stocks in the same industry
Biotechnology
ACTU
Main Stock$1.95
Tradestie Score
54
Market Cap
$161.08M
Analyst Upside
+411.7%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$5.30
|
$158.43M | - | 52 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$24.48
|
$154.27M | - | 58 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.75
|
$133.50M | - | 66 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.01
|
$114.01M | - | 55 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.91
|
$110.20M | - | 61 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.51
|
$71.69M | - | 58 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.04
|
$67.94M | - | 59 | Compare |
|
ACCL
ACCL
|
$1.72
|
$24.41M | 25.0 | 57 | Compare |
|
ACTL
ACTL
|
- | - | - | - | Compare |
|
CPWR
CPWR
|
- | - | - | - | Compare |
More ACTU Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry